Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Caraway

Request full access

invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy

Cambridge, United StatesFounded 2018Biotech & Life Sciences

About Caraway

Caraway Therapeutics is an emerging biopharmaceutical company focused on developing novel treatments for debilitating neurodegenerative diseases. The company is pioneering the use of cellular recycling processes, known as autophagy, to clear toxic materials and defective cellular components from neurons. This innovative approach aims to preserve neuron function and slow disease progression. Caraway Therapeutics primarily serves patients suffering from neurodegenerative conditions, a market characterized by high unmet medical needs and significant demand for effective therapies. The company's business model revolves around rigorous scientific research and development, leveraging genetically defined targets to identify potential therapeutic candidates. Revenue is generated through research grants, partnerships, and eventual commercialization of successful treatments.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
4
Open positions
None listed
Dealroom signal
25.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Pay Per Result, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Nov 2023 $610M $610M Merck & Co. ↗
SERIES A✓Equity / VC Nov 2018 $23M $92M Mayo Clinic · Abbvie Biotech Ventures · MRL Ventures · Amgen Ventures ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Caraway website traffic

Latest recorded traffic for Caraway is 280 monthly website visits, down 54.1% over the last three months. Caraway's team declined 82.6% over the past year.

Latest monthly visits280 3-month web change-54.1% 1-year team growth-82.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Caraway in the Cambridge ecosystem

Live from Dealroom

The Caraway office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Abbvie Biotech Ventures
  • MRL Ventures
  • Mayo Clinic
  • Amgen Ventures
  • Alexandria Venture Investments

Other known investors2 additional known investors

  • Merck & Co.
  • SV Health Investors
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Caraway on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Caraway’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.